vs
MERCANTILE BANK CORP（MBWM）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是MERCANTILE BANK CORP的1.0倍（$69.8M vs $67.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 33.6%，领先350.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.1%）
泰米尔纳德商业银行（TMB）是一家印度银行，总部位于泰米尔纳德邦杜蒂戈林。该行始建于1921年，最初名为纳达尔银行，1962年11月更名为泰米尔纳德商业银行，以拓展纳达尔社群以外的业务。目前该银行在印度全境拥有600家全功能网点、12个区域办事处及各类配套服务中心与自助设施。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MBWM vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$67.6M
净利率更高
RIGL
高出350.5%
33.6%
两年增速更快
RIGL
近两年复合增速
9.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $67.6M | $69.8M |
| 净利润 | $22.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 33.6% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 16.1% | 1769.2% |
| 每股收益（稀释后） | $1.32 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MBWMRIGL
| Q1 26 | $67.6M | — | ||
| Q4 25 | $62.1M | $69.8M | ||
| Q3 25 | $62.4M | $69.5M | ||
| Q2 25 | $60.9M | $101.7M | ||
| Q1 25 | $57.3M | $53.3M | ||
| Q4 24 | $58.5M | $57.6M | ||
| Q3 24 | $58.0M | $55.3M | ||
| Q2 24 | $56.8M | $36.8M |
净利润MBWMRIGL
| Q1 26 | $22.7M | — | ||
| Q4 25 | $22.8M | $268.1M | ||
| Q3 25 | $23.8M | $27.9M | ||
| Q2 25 | $22.6M | $59.6M | ||
| Q1 25 | $19.5M | $11.4M | ||
| Q4 24 | $19.6M | $14.3M | ||
| Q3 24 | $19.6M | $12.4M | ||
| Q2 24 | $18.8M | $-1.0M |
毛利率MBWMRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率MBWMRIGL
| Q1 26 | — | — | ||
| Q4 25 | 42.0% | 33.2% | ||
| Q3 25 | 44.0% | 40.9% | ||
| Q2 25 | 42.6% | 60.1% | ||
| Q1 25 | 42.0% | 23.9% | ||
| Q4 24 | 39.7% | 28.9% | ||
| Q3 24 | 42.4% | 25.4% | ||
| Q2 24 | 41.4% | 1.2% |
净利率MBWMRIGL
| Q1 26 | 33.6% | — | ||
| Q4 25 | 36.8% | 384.0% | ||
| Q3 25 | 38.1% | 40.2% | ||
| Q2 25 | 37.1% | 58.6% | ||
| Q1 25 | 34.1% | 21.5% | ||
| Q4 24 | 33.5% | 24.9% | ||
| Q3 24 | 33.8% | 22.5% | ||
| Q2 24 | 33.1% | -2.8% |
每股收益（稀释后）MBWMRIGL
| Q1 26 | $1.32 | — | ||
| Q4 25 | $1.41 | $14.11 | ||
| Q3 25 | $1.46 | $1.46 | ||
| Q2 25 | $1.39 | $3.28 | ||
| Q1 25 | $1.21 | $0.63 | ||
| Q4 24 | $1.20 | $0.82 | ||
| Q3 24 | $1.22 | $0.70 | ||
| Q2 24 | $1.17 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $1.5M | $52.5M |
| 股东权益账面价值 | $736.9M | $391.5M |
| 总资产 | $6.9B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MBWMRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M |
总债务MBWMRIGL
| Q1 26 | $1.5M | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益MBWMRIGL
| Q1 26 | $736.9M | — | ||
| Q4 25 | $724.9M | $391.5M | ||
| Q3 25 | $657.6M | $117.6M | ||
| Q2 25 | $631.5M | $81.9M | ||
| Q1 25 | $608.3M | $18.6M | ||
| Q4 24 | $584.5M | $3.3M | ||
| Q3 24 | $583.3M | $-14.6M | ||
| Q2 24 | $551.2M | $-29.9M |
总资产MBWMRIGL
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.8B | $513.6M | ||
| Q3 25 | $6.3B | $242.5M | ||
| Q2 25 | $6.2B | $206.7M | ||
| Q1 25 | $6.1B | $176.0M | ||
| Q4 24 | $6.1B | $164.0M | ||
| Q3 24 | $5.9B | $139.4M | ||
| Q2 24 | $5.6B | $128.4M |
负债/权益比MBWMRIGL
| Q1 26 | 0.00× | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MBWMRIGL
| Q1 26 | — | — | ||
| Q4 25 | $18.0M | $22.0M | ||
| Q3 25 | $23.1M | $24.0M | ||
| Q2 25 | $-7.8M | $30.5M | ||
| Q1 25 | $-3.0M | $-893.0K | ||
| Q4 24 | $101.1M | $14.5M | ||
| Q3 24 | $-8.1M | $21.7M | ||
| Q2 24 | $9.1M | $302.0K |
现金转化率MBWMRIGL
| Q1 26 | — | — | ||
| Q4 25 | 0.79× | 0.08× | ||
| Q3 25 | 0.97× | 0.86× | ||
| Q2 25 | -0.35× | 0.51× | ||
| Q1 25 | -0.15× | -0.08× | ||
| Q4 24 | 5.15× | 1.01× | ||
| Q3 24 | -0.41× | 1.75× | ||
| Q2 24 | 0.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
RIGL
暂无分部数据
